Our study demonstrated that VILIP3, a differentially expressed NCS protein in AD, ameliorates cognitive deficits and neuropathological impairments during AD, potentially by modulating the Nrf2 signaling pathway to attenuate oxidative stress and reduce neuronal apoptosis. This evidence concerns the gene HPCAL1 and Cognitive impairment.